Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Clinical trial NCT00170469 · COMPLETED

Trial details

NCT number: NCT00170469
Sponsor: PharmAthene UK Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bacillus Anthracis (Anthrax)

Start date: 2005-03-01
Primary completion: 2007-02-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.